Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP

Connective tissue growth factor (CTGF) is a cysteine‐rich peptide synthesized and secreted by fibroblastic cells after activation with transforming growth factor beta (TGF‐β) that acts as a downstream mediator of TGF‐β‐induced fibroblast proliferation. We performed in vitro and in vivo studies to determine whether CTGF is also essential for TGF‐β‐induced fibroblast collagen synthesis. In vitro studies with normal rat kidney (NRK) fibroblasts demonstrated CTGF potently induces collagen synthesis and transfection with an antisense CTGF gene blocked TGF‐β stimulated collagen synthesis. Moreover, TGF‐β‐induced collagen synthesis in both NRK and human foreskin fibroblasts was effectively blocked with specific anti‐CTGF antibodies and by suppressing TGF‐β‐induced CTGF gene expression by elevating intracellular cAMP levels with either membrane‐permeable 8‐Br‐cAMP or an adenylyl cyclase activator, cholera toxin (CTX). cAMP also inhibited collagen synthesis induced by CTGF itself, in contrast to its previously reported lack of effect on CTGF‐induced DNA synthesis. In animal assays, CTX injected intradermally in transgenic mice suppressed TGF‐β activation of a human CTGF promoter/lacZ reporter transgene. Both 8‐Br‐cAMP and CTX blocked TGF‐β‐induced collagen deposition in a wound chamber model of fibrosis in rats. CTX also reduced dermal granulation tissue fibroblast population increases induced by TGF‐β in neonatal mice, but not increases induced by CTGF or TGF‐β combined with CTGF. Our data indicate that CTGF mediates TGF‐β‐induced fibroblast collagen synthesis and that in vivo blockade of CTGF synthesis or action reduces TGF‐β‐induced granulation tissue formation by inhibiting both collagen synthesis and fibroblast accumulation.—Duncan, M. R., Frazier, K. S. Abramson, S., Williams, S., Klapper, H., Huang, X., Grotendorst, G. R. Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP. FASEB J. 13, 1774–1786 (1999)

[1]  Gary R. Grotendorst,et al.  Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Gary R. Grotendorst,et al.  Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? , 1998, The international journal of biochemistry & cell biology.

[3]  J. Lasky,et al.  Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[4]  A. Roberts,et al.  Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.

[5]  R. Bende,et al.  Expression of connective tissue growth factor in human renal fibrosis. , 1998, Kidney international.

[6]  Gary R. Grotendorst Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .

[7]  A. Mallat,et al.  Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast‐like cells , 1997, Hepatology.

[8]  W. März,et al.  Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. , 1997, Circulation.

[9]  Gary R. Grotendorst,et al.  Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  Gary R. Grotendorst,et al.  Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. , 1997, The international journal of biochemistry & cell biology.

[11]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[12]  Gary R. Grotendorst,et al.  A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  Gary R. Grotendorst,et al.  Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. , 1996, The Journal of investigative dermatology.

[14]  T. C. Peterson,et al.  Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. , 1996, Immunopharmacology.

[15]  Gary R. Grotendorst,et al.  Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. , 1995, The Journal of investigative dermatology.

[16]  B. Berman,et al.  Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. , 1995, The Journal of investigative dermatology.

[17]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[18]  R. Clark Basics of cutaneous wound repair. , 1993, The Journal of dermatologic surgery and oncology.

[19]  Gary R. Grotendorst,et al.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.

[20]  P. Bornstein,et al.  Regulation of expression of the type I collagen genes. , 1993, American journal of medical genetics.

[21]  M. Nilsen-Hamilton,et al.  Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression. , 1992, The Biochemical journal.

[22]  B. Berman,et al.  Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. , 1992, The Journal of investigative dermatology.

[23]  E. Linney,et al.  Transgenic indicator mice for studying activated retinoic acid receptors during development. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Lycke,et al.  Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. , 1992, Immunology.

[25]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[26]  Gary R. Grotendorst,et al.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.

[27]  K. Lapis,et al.  Immunohistochemical detection of transforming growth factor‐β1 in fibrotic liver diseases , 1991, Hepatology.

[28]  D. Brenner,et al.  Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter , 1991, Molecular and cellular biology.

[29]  S. Jimenez,et al.  Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. , 1990, The Journal of investigative dermatology.

[30]  E. Leroy,et al.  A possible role for transforming growth factor-beta in systemic sclerosis. , 1990, The Journal of investigative dermatology.

[31]  A. Rizzino,et al.  Inhibitory effects of transforming growth factor-beta on laminin production and growth exhibited by endoderm-like cells derived from embryonal carcinoma cells. , 1989, Differentiation; research in biological diversity.

[32]  K. Hruska,et al.  Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells. , 1989, Endocrinology.

[33]  B. Berman,et al.  Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. , 1989, The Journal of investigative dermatology.

[34]  B. Berman,et al.  Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. , 1989, The Journal of investigative dermatology.

[35]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.

[36]  P. Bornstein,et al.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[38]  J. Rosenbloom,et al.  PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. , 1987, Biochemical and biophysical research communications.

[39]  L. Williams,et al.  Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[40]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[41]  H. Moses,et al.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.

[42]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[45]  Gary R. Grotendorst,et al.  Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. , 1985, The Journal of clinical investigation.

[46]  M. Sporn,et al.  Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. , 1983, Science.

[47]  W. Harvey,et al.  A quantitative assay for collagen synthesis in microwell fibroblast cultures. , 1979, Analytical biochemistry.

[48]  G. Todaro,et al.  Growth factors from murine sarcoma virus-transformed cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Todaro,et al.  Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation , 1978, Journal of cellular physiology.

[50]  T. K. Hunt,et al.  Respiratory gas tensions and pH in healing wounds. , 1967, American journal of surgery.

[51]  J. Schilling,et al.  Wound healing: a comparative study of the histochemical changes in granulation tissue contained in stainless steel wire mesh and polyvinyl sponge cylinders. , 1959, Surgery.